Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Phibro Animal Health is focusing on new developments along with incremental registrations and growing volumes of existing vaccine technologies.

Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.

Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks presents investors with the better value opportu...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

PAHC's prospering Vaccine business sparks optimism for future growth. However, headwinds such as unfavorable foreign exchange might hamper the company's operations.

PAHC shares gain owing to the remarkable performance of the Animal Health business and potential in the emerging markets.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

An ongoing rise in demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. RMD, HAE, PAHC and AGIO are well-poised to gain from the favorable fac...

PAHC's Animal Health business, along with flourishing Mineral Nutrition and Performance Product businesses, sparks optimism for future growth.

Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their bu...

Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.

Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Explore Phibro's (PAHC) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Phibro Animal Health Corporation (NASDAQ:PAHC ) Q1 2025 Earnings Conference Call November 7, 2024 9:00 AM ET Company Participants Glenn David - Chief Financial Officer Jack Bendheim - Chairman-Board o...

Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Abbott (ABT). But which of these two stocks offers value investors a better b...

PAHC delivers strong growth across all its segments in the first quarter of fiscal 2025.